The Hudson Bay Company Analysis
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: Implications for health-care utilization in Australia
Adolescents’ Intake of Junk Food: Processes and Mechanisms Driving Consumption Similarities Among Friends
Exercise and eating behaviour: the role of mindfulness
NHS in England underfunded?
Prescriber feedback ineffective
Australian drug expenditure up 8.3%
‘Cheers’ to acamprosate in reducing the costs of alcoholism
News in brief …
Prophylactic ondansetron worth it in paediatric PONV
Hep A shots recommended for children in high-risk US states
Unrelated disorders undertreated in patients with chronic disease
Iron dextran cost effective in ESRD anaemia
Provider backlash to US HHS privacy rule expected
US treatment of acute MI less than ideal
Quality improvement strategies for clinical practice
NICE guidance for economic evaluation updated
IOM report calls for repair of US public health system
At-risk patients with MI don’t get the best possible care
